TET2 c.3619G>A ;(p.E1207K)

Variant ID: 4-106164751-G-A

NM_001127208.2(TET2):c.3619G>A;(p.E1207K)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

Blood Advances
Lafage-Pochitaloff, Marina M; Gerby, Bastien B; Baccini, Véronique V; Largeaud, Laetitia L; Fregona, Vincent V; Prade, Naïs N; Juvin, Pierre-Yves PY; Jamrog, Laura L; Bories, Pierre P; Hébrard, Sylvie S; Lagarde, Stéphanie S; Mansat-De Mas, Véronique V; Dovey, Oliver M OM; Yusa, Kosuke K; Vassiliou, George S GS; Jansen, Joop H JH; Tekath, Tobias T; Rombaut, David D; Ameye, Geneviève G; Barin, Carole C; Bidet, Audrey A; Boudjarane, John J; Collonge-Rame, Marie-Agnès MA; Gervais, Carine C; Ittel, Antoine A; Lefebvre, Christine C; Luquet, Isabelle I; Michaux, Lucienne L; Nadal, Nathalie N; Poirel, Hélène A HA; Radford-Weiss, Isabelle I; Ribourtout, Bénédicte B; Richebourg, Steven S; Struski, Stéphanie S; Terré, Christine C; Tigaud, Isabelle I; Penther, Dominique D; Eclache, Virginie V; Fontenay, Michaela M; Broccardo, Cyril C; Delabesse, Eric E
Publication Date: 2022-01-25

Variant appearance in text: TET2: 3619G>A; Glu1207Lys
PubMed Link: 34638130
Variant Present in the following documents:
  • advancesADV2021005311-suppl1.pdf
View BVdb publication page



Comprehensive next-generation profiling of clonal hematopoiesis in cancer patients using paired tumor-blood sequencing for guiding personalized therapies.

Clinical And Translational Medicine
Li, Ziyang Z; Huang, Wensou W; Yin, Jiani C JC; Na, Chenglong C; Wu, Xue X; Shao, Yang Y; Ding, Huaxin H; Li, Jinming J
Publication Date: 2020-11

Variant appearance in text: TET2: 3619G>A; E1207K
PubMed Link: 33252848
Variant Present in the following documents:
  • CTM2-10-e222-s003.xlsx, sheet 1
View BVdb publication page